Julius Knowles - 03 Jan 2022 Form 4 Insider Report for Keros Therapeutics, Inc. (KROS)

Role
Director
Signature
/s/ Keith Regnante, Attorney-in-Fact
Issuer symbol
KROS
Transactions as of
03 Jan 2022
Net transactions value
-$2,756,116
Form type
4
Filing time
05 Jan 2022, 18:14:26 UTC
Previous filing
03 Dec 2021
Next filing
03 Jun 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KROS Common Stock Sale $208,984 -3,678 -0.99% $56.82 366,738 03 Jan 2022 See footnote F1, F2, F3
transaction KROS Common Stock Sale $136,709 -2,406 -0.96% $56.82 249,130 03 Jan 2022 See footnote F1, F2, F4
transaction KROS Common Stock Sale $294,586 -5,094 -1.4% $57.83 361,644 03 Jan 2022 See footnote F1, F3, F5
transaction KROS Common Stock Sale $191,880 -3,318 -1.3% $57.83 245,812 03 Jan 2022 See footnote F1, F4, F5
transaction KROS Common Stock Sale $308,715 -5,236 -1.4% $58.96 356,408 03 Jan 2022 See footnote F1, F3, F6
transaction KROS Common Stock Sale $201,172 -3,412 -1.4% $58.96 242,400 03 Jan 2022 See footnote F1, F4, F6
transaction KROS Common Stock Sale $14,791 -249 -0.07% $59.40 356,159 03 Jan 2022 See footnote F1, F3, F7
transaction KROS Common Stock Sale $9,623 -162 -0.07% $59.40 242,238 03 Jan 2022 See footnote F1, F4, F7
transaction KROS Common Stock Sale $43,630 -794 -0.22% $54.95 355,365 04 Jan 2022 See footnote F1, F3, F8
transaction KROS Common Stock Sale $28,794 -524 -0.22% $54.95 241,714 04 Jan 2022 See footnote F1, F4, F8
transaction KROS Common Stock Sale $119,156 -2,124 -0.6% $56.10 353,241 04 Jan 2022 See footnote F1, F3, F9
transaction KROS Common Stock Sale $77,586 -1,383 -0.57% $56.10 240,331 04 Jan 2022 See footnote F1, F4, F9
transaction KROS Common Stock Sale $97,214 -1,707 -0.48% $56.95 351,534 04 Jan 2022 See footnote F1, F3, F10
transaction KROS Common Stock Sale $63,385 -1,113 -0.46% $56.95 239,218 04 Jan 2022 See footnote F1, F4, F10
transaction KROS Common Stock Sale $240,716 -4,151 -1.2% $57.99 347,383 04 Jan 2022 See footnote F1, F3, F11
transaction KROS Common Stock Sale $156,805 -2,704 -1.1% $57.99 236,514 04 Jan 2022 See footnote F1, F4, F11
transaction KROS Common Stock Sale $198,182 -3,367 -0.97% $58.86 344,016 04 Jan 2022 See footnote F1, F3, F12
transaction KROS Common Stock Sale $129,198 -2,195 -0.93% $58.86 234,319 04 Jan 2022 See footnote F1, F4, F12
transaction KROS Common Stock Sale $23,979 -419 -0.12% $57.23 343,597 05 Jan 2022 See footnote F1, F3, F13
transaction KROS Common Stock Sale $15,509 -271 -0.12% $57.23 234,048 05 Jan 2022 See footnote F1, F4, F13
transaction KROS Common Stock Sale $78,919 -1,356 -0.39% $58.20 342,241 05 Jan 2022 See footnote F1, F3, F14
transaction KROS Common Stock Sale $51,565 -886 -0.38% $58.20 233,162 05 Jan 2022 See footnote F1, F4, F14
transaction KROS Common Stock Sale $39,353 -667 -0.19% $59.00 341,574 05 Jan 2022 See footnote F1, F3, F15
transaction KROS Common Stock Sale $25,665 -435 -0.19% $59.00 232,727 05 Jan 2022 See footnote F1, F4, F15
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.30 to $57.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (5), (6), (7), (8), (9), (10), (11), (12), (13), (14) and (15).
F3 The securities are held by Partners Innovation Fund, LLC ("PIF I"). Partners Innovation Fund, LLC ("Partners GP I") is the ultimate general partner of PIF I. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP I and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF I.
F4 The securities are held by Partners Innovation Fund II, L.P. ("PIF II"). Partners Innovation Fund II, LLC ("Partners GP II") is the ultimate general partner of PIF II. The Reporting Person, a member of the board of directors of the Issuer, is a partner of Partners GP II and as a result, may be deemed to share voting and investment power with respect to the shares held by PIF II.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.30 to $58.24 inclusive.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.35 to $59.33 inclusive.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.36 to $59.45 inclusive.
F8 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.50 to $55.48 inclusive.
F9 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.555 to $56.53 inclusive.
F10 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.56 to $57.53 inclusive.
F11 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.56 to $58.55 inclusive.
F12 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.57 to $59.36 inclusive.
F13 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.63 to $57.56 inclusive.
F14 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.63 to $58.62 inclusive.
F15 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.76 to $59.25 inclusive.